升高的PCSK9水平通过TLR4/NF-kappaB通路激活促进了在香烟烟雾提取物诱导的COPD模型中的人类肺微血管内皮细胞亡
Yunxia Li1, Fengzhen He2, Shasha Zhao3
1PCCM Ward II, The First Affiliated Hospital of Xinxiang Medical University, No.88 Jiankang Road, Weihui, 453100, Henan, China. liyunxi471@sina.com.
Applied biochemistry and biotechnology
|July 17, 2025
概括
在慢性阻塞性肺病 (COPD) 中,蛋白转化酶亚提利辛/凯辛9型 (PCSK9) 的上调. 沉默PCSK9可以减少肺损伤,炎症和亡,这表明PCSK9是COPD的潜在治疗点.
科学领域:
- 肺部医学 肺部医学
- 分子生物学分子生物学
- 心血管研究研究心血管研究
背景情况:
- 慢性阻塞性肺病 (COPD) 是一种与心血管风险相关的渐进性肺病.
- 蛋白转化酶亚素/素9型 (PCSK9) 影响胆固醇代谢,并与内皮功能障碍有关.
- 了解PCSK9在COPD发病过程中的作用对于开发新疗法至关重要.
研究的目的:
- 为了研究COPD肺组织中的PCSK9表达.
- 为了检查PCSK9调节在体外和体内暴露于香烟烟雾的反应.
- 在COPD模型中评估PCSK9抑制的治疗潜力.
主要方法:
- 在人类COPD肺组织中分析PCSK9表达.
- 人类肺微血管内皮细胞 (HPMECs) 暴露于香烟烟雾提取物 (CSE).
- 使用暴露于香烟烟雾 (CS) 的小鼠模型.
- PCSK9沉默实验和炎症标志物,细胞亡和细胞透的评估.
主要成果:
- 与对照组相比,COPD肺部的PCSK9表达显著增加.
- 在HPMEC和暴露于CS/CSE的小鼠中,PCSK9水平增加.
- 沉默PCSK9可以减轻CS/CSE引起的肺损伤,炎症和亡.
- PCSK9 Knockdown 抑制了关键的炎症途径 (NF-κB,NLRP3炎症体) 和亡标记物 (Bcl-2,Bax).
结论:
- PCSK9在COPD的进展中起着至关重要的作用.
- 抑制PCSK9证明了减少COPD肺损伤和炎症的治疗潜力.
- 向PCSK9为COPD治疗提供了一个有希望的策略.
相关概念视频
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
3.1K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
3.1K
01:20COPD: Pathogenesis and Clinical Features
529
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
529
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.9K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.9K
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.9K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.9K
02:26NF-κB-dependent Signaling Pathway
7.9K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.9K
01:22Chronic Obstructive Pulmonary Disease
1.4K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.4K